Related Experiment Video
Updated: Jun 8, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Relationship between a diagnosis of kidney failure and heart diseases in patients with hyperkalemia
Josep Darbà1, Meritxell Ascanio2, Ainoa Agüera2
1Department of Economics, Universitat de Barcelona, Barcelona, Spain.
Insights
Diagnoses of kidney failure and heart disease significantly increase hyperkalemia risk. This study highlights the need for close patient monitoring to prevent future complications.
Area of Science:
- Nephrology
- Cardiology
- Endocrinology
Background:
- Hyperkalemia is a critical electrolyte imbalance.
- Kidney failure and heart disease are known risk factors for hyperkalemia.
- The causal relationship and diagnostic impact require further empirical investigation.
Purpose of the Study:
- To determine the association between kidney failure and heart disease diagnoses and the incidence of hyperkalemia.
- To evaluate the causal impact of these diagnoses on hyperkalemia using a regression discontinuity design.
- To provide empirical insights into the management of patients with co-existing conditions.
Main Methods:
- Utilized a fuzzy regression discontinuity design (RDD).
- Harnessed the potassium level threshold (6 mEq/L) as a diagnostic criterion for hyperkalemia.
- Analyzed patient diagnosis data for kidney failure and heart disease.
Main Results:
- A diagnosis of kidney failure or heart disease significantly increases the risk of developing hyperkalemia.
- Kidney failure diagnosis probability increased by 11.2% around the 6 mEq/L potassium cut-off.
- Hypertension and depression diagnoses were also associated with increased hyperkalemia likelihood (6.8% and 8.8% respectively).
Conclusions:
- Kidney failure and heart disease have a significant causal impact on hyperkalemia development.
- Monitoring patients with these conditions is crucial for preventing severe complications.
- Findings were robust across various analytical specifications and placebo tests.
Objectives:
This study seeks to determine the association between kidney failure and heart diseases by examining how they influence the diagnosis of hyperkalemia.
Methods:
We employ a fuzzy regression discontinuity design (RDD) by harnessing the inherent threshold in potassium levels, which serves as a diagnostic criterion for hyperkalemia. Simultaneously, we utilize patient diagnosis data related to kidney failure and heart diseases. This approach allows us to evaluate the causal impact of both diagnoses on hyperkalemia.
Results:
Significant overall increases in the risk of developing hyperkalemia are evident subsequent to a diagnosis of kidney failure or heart disease. The study finds that the probability of receiving a kidney failure diagnosis increases by 11.2% regarding a cut-off of 6 mEq/L of potassium. In addition, there is a 6.8% likelihood of experiencing hyperkalemia in the case of a prior diagnosis of hypertension, and an 8.8% probability in the case of a diagnosis of depression. The findings remain robust when considering alternative parametric and non-parametric specifications as well as placebo tests.
Conclusions:
This study provides new empirical insights into the causal impact of kidney failure and heart disease, underscoring the significance of monitoring such patients to prevent serious complications in the future.
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Heart Failure
Heart Failure Drugs: Inotropic Agents
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Antihypertensive Drugs: Potassium-Sparing Diuretics

